Zai Lab Says China Approves New Drug Application for Lung Cancer Treatment Augtyro
Zai Lab Says China Approves New Drug Application for Lung Cancer Treatment Augtyro
Zai Lab说中国批准了治疗肺癌的新药申请 Augtyro
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册